A couple months ago, the product was approved by the FDA and is now coming to market. According to the article hospitals and health organizations will be the first visits for marketing and sales, rather than a direct to consumer sale. Intel also has a pretty large interest in biotech related to healthcare as well.
Intel Corp. thinks the future of health care lies at home, and its first-ever medical device bets big on that vision. The Santa Clara, Calif.-based technology giant is making its foray into the medical market with the Sept. 1 launch of a high-tech care management system that allows doctors to monitor chronic disease patients at home. The launch, which follows two years of development, will likely be the first of many medical devices introduced by Intel in the coming years.
An Intel sales team will target health systems, disease management companies and hospitals. Integrated health care systems, such as Kaiser Permanente which operates hospitals and an insurance company plus employs physicians, may be an especially receptive market, Intel officials said, because they have a strong financial incentive to keep patients healthy and out of the hospital.